Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to spot cerebral palsy earlier in At-Risk babies

NCT ID NCT06857539

Knowledge-focused Sponsor: University College Cork Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Cerebral palsy (CP) is a brain injury that affects movement, but diagnosing it can take up to 2 years. This study follows 600 high-risk infants (premature, brain-injured, or with abnormal exams) across Irish hospitals. Researchers will use EEG sleep tests, protein markers, and cognitive assessments to see if they can predict CP and other developmental issues earlier. The goal is to speed up diagnosis and improve support for affected children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to earlier diagnosis of cerebral palsy and better prediction of developmental issues, allowing for earlier intervention.
What could go wrong
This is an observational study, not testing a treatment. It may not change outcomes directly, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All infants considered high risk for a diagnosis of cerebral palsy and neuro-developmental impairment will be eligible, specifically: All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight All encephalopathic infants Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam) All full-term infants (\>37 weeks gestation), without requirement for admission to the NICU will be eligible to be enrolled in the study as the control arm of the study

Ages

0 days to 4 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (High Risk Group) : * Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol. * All infants considered high risk for a diagnosis of cerebral palsy and neuro-developmental impairment will be eligible, specifically including: * All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight * All encephalopathic infants * Neurological risk factors (e.g., cerebral birth defect, injury/malformation on neuroimaging, persistently abnormal neurological exam) (Control Group) -A control arm will also be recruited. Exclusion Criteria: * Death prior to discharge from the neonatal unit (High-Risk Infants only) * No parental consent (High-Risk and Control Infants)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain hypoxia - ischemia cerebral palsy Cognitive Dysfunction developmental disability perinatal asphyxia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy Cerebral palsy (CP) Cerebral palsy children Cognitive development Hie - hypoxic - ischemic encephalopathy High-risk infants Intellectual and developmental disabilities Motor impairment Prematurity; extreme Preterm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Coombe Women and Infant's Hospital

    NOT_YET_RECRUITING

    Dublin, Ireland

  • Cork University Maternity Hospital

    RECRUITING

    Cork, Ireland

  • INFANT Centre, University College Cork

    RECRUITING

    Cork, Ireland

  • The Rotunda Hospital

    RECRUITING

    Dublin, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.